Cargando…

Pacemakers as Atrial Fibrillation Detectors: Finding Racial Differences and Opportunities for Preventing Stroke

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889161/ https://www.ncbi.nlm.nih.gov/pubmed/27172909 http://dx.doi.org/10.1161/JAHA.116.002029

Ejemplares similares

Pacemakers as Atrial Fibrillation Detectors: Finding Racial Differences and Opportunities for Preventing Stroke
por: Meschia, James F.
Publicado: (2016)

Racial differences in atrial fibrillation-related strokes and mortality
por: Kang, D S, et al.
Publicado: (2023)

Racial and Ethnic Differences in the Management of Atrial Fibrillation
por: Tamirisa, Kamala P., et al.
Publicado: (2021)

Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation
por: Guo, Jingchuan, et al.
Publicado: (2021)

Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation
por: Sandgren, Emma, et al.
Publicado: (2018)

Racial differences in atrial fibrillation-related bleeding and mortality
por: Kang, D S, et al.
Publicado: (2023)

Atrial Fibrillation in Patients with Permanent VVI Pacemakers: Risk Factors for Atrial Fibrillation
por: Cho, Jeong Gwan, et al.
Publicado: (1997)

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Publicado: (2018)

Correction to: Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation
Publicado: (2022)

Associations of dietary patterns with risk of incident atrial fibrillation in the REasons for Geographic And Racial Differences in Stroke (REGARDS)
por: Garg, Parveen K., et al.
Publicado: (2023)

Correction: Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Publicado: (2021)

Stroke Prevention in Patients with Atrial Fibrillation
por: Kowey, Peter R.
Publicado: (2018)

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation
por: Poposka, Lidija, et al.
Publicado: (2016)

Correction: IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
por: Ziegler, Louise, et al.
Publicado: (2022)

Correction: Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial
Publicado: (2023)

Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation
por: O’Neal, Wesley T., et al.
Publicado: (2019)

Continuous monitoring of sleep‐disordered breathing with pacemakers: Indexes for risk stratification of atrial fibrillation and risk of stroke
por: Mazza, Andrea, et al.
Publicado: (2020)

Rates of Atrial Fibrillation in Black Versus White Patients With Pacemakers
por: Kamel, Hooman, et al.
Publicado: (2016)

Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
por: Rhew, Shi Hyun, et al.
Publicado: (2017)

Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016)

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
por: Patel, Taral K., et al.
Publicado: (2012)

Improving stroke prevention in patients with atrial fibrillation
por: Arts, Derk L, et al.
Publicado: (2013)

Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
por: Ahmad, Yousif, et al.
Publicado: (2012)

Non-Pharmacological Stroke Prevention in Atrial Fibrillation
por: Anduaga, Iñigo, et al.
Publicado: (2023)

Correction to: MR‑imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke
por: Vollmuth, Christoph, et al.
Publicado: (2020)

Correction to: Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation
Publicado: (2022)

Association of hypertension severity and control with risk of incident atrial fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study
por: Garg, Parveen K., et al.
Publicado: (2023)

Left Atrial Appendage Closure to Prevent Strokes and Ligation to Prevent Atrial Fibrillation
por: Ellis, Christopher R.
Publicado: (2017)

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
por: Wilson, Duncan, et al.
Publicado: (2019)

Single-Chamber Leadless Cardiac Pacemaker in Patients Without Atrial Fibrillation: Findings From Campania Leadless Registry
por: Russo, Vincenzo, et al.
Publicado: (2022)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
por: Kalus, James S
Publicado: (2013)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Correction: Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
Publicado: (2022)

Racial/ethnic and sex differences in safety outcomes and atrial fibrillation/atrial flutter–related acute healthcare utilization after catheter ablation of atrial fibrillation
por: Jackson, Larry R., et al.
Publicado: (2023)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

Stroke Prevention in Atrial Fibrillation: Focus on Latin America
por: Massaro, Ayrton R., et al.
Publicado: (2016)

The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
por: Kim, Young-Hoon, et al.
Publicado: (2016)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
por: Ahmad, Yousif, et al.
Publicado: (2012)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6eciltjbjcq52d6gedrp5jf838